ACSL4 and hepatocellular carcinoma: A functional analysis assessed the targeting of Acyl-CoA synthetase long-chain family member 4 (ACSL4), a necessary enzyme for catalyzing lipid peroxidation during ferroptosis, suggesting the silencing of miR-23a-3p as a promising option in sorafenib-resistant HCC patients [73].